InvestorsHub Logo
Followers 98
Posts 5356
Boards Moderated 0
Alias Born 08/27/2011

Re: biopharm post# 216068

Sunday, 04/19/2015 10:28:12 AM

Sunday, April 19, 2015 10:28:12 AM

Post# of 346402
Biopharm we have the "holy grail" bavituximab will help ALL patients with cancer. If used upon diagnosis in all cancers there is a strong chance a healthy immune system could cure the patient.

Bavituximab will be soc initial therapy for all patients with cancer in five years then the practitioner will prescribe the best cocktail ctl4 pd1 chemo radiation etc if the immune system is not enough.

Hard to believe when we're sitting at 1.30/share?

Markets have a way of correcting themselves. Correction coming in 2015 imo, next week next month?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News